Andee M. Beierle

Andee M. Beierle

Auto-generated profile, based on publicly available information

Andee M. Beierle

Department of Radiation Oncology, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, AL 35233, USA

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 October 2024 in Journal of Biological Chemistry
Verified
Journal Article
Open access
NNNazia Nazam
Nazia Nazam
MEMichael H. Erwin
Michael H. Erwin
JJJanet Julson
Janet Julson
CQColin H. Quinn
Colin H. Quinn
ABAndee M. Beierle
Andee M. Beierle
EBElizabeth Beierle
Elizabeth Beierle
Leptomeningeal dissemination (LMD) is the primary cause of treatment failure in children with group 3 medulloblastoma (MB). Building on our previous work on protein phosphatase 2A (PP2A) activation in MB, here we present preclinical and molecular data on the effects of two novel classes of PP2A activators on disease processes of LMD in group 3 MB. The PP2A activators used in this study are ATUX-6156 and ATUX6954 (diarylmethylcycloamine sulfonylureas), and ATUX-1215 and ATUX-5800 (diarylmethyl-4-aminotetrahydropyran-sulfonamides). Treatment with these compounds led to suppression of the endogenous PP2A inhibitor, cancerous inhibitor of PP2A (CIP2A), enhanced phosphatase activity (10-60%), and reduced MB viability, migration, and invasion, prerequisites for MB cells to access the cerebrospinal fluid, affecting the initiation stage of LMD. PP2A activator treatment of MB cells led to apoptosis mediated via caspase 9/PARP signaling due to decreased phosphorylation of Bad, impeding the dispersal stage of LMD. Cell proliferation and LMD-driving cellular traits and molecules pertinent to the third stage, colonization, were also affected. Treatment with ATUX-1215 or ATUX-5800 prevented LMD in an intraventricular murine model of MB, possibly mediated by disruption of the CCL2-CCR2 axis by altered NF-kB phosphorylation via disrupted AKT signaling. The present investigation offers proof-of-principle data for PP2A-based reactivation therapy for Group 3 MB and provides the first indications that PP2A reactivation may challenge the current paradigm in targeting the 3-stage process of MB LMD. Further investigations of PP2A activators are warranted as these compounds may prove beneficial as therapeutics for MB.

23 September 2025 in Clinical and Translational Radiation Oncology
Verified
Journal Article
Open access
TSTaylor L. Schanel
Taylor L. Schanel
MKManoj Kumar
Manoj Kumar
LNLauren C Nassour-Caswell
Lauren C Nassour-Caswell
SCSreelakshmi Cherakara
Sreelakshmi Cherakara
RPRhea Pandit
Rhea Pandit
CWChristopher Douglas Willey
Christopher Douglas Willey
Ultra-high dose rate (FLASH-RT) and conventional proton beam radiotherapy to intracranial glioblastoma PDX were compared for tumor control and normal tissue toxicity via DNA and RNA damage response markers. Both conventional and FLASH radiotherapy yielded similar survival benefits; however, conventional radiotherapy resulted in greater normal tissue DNA and RNA damage.

1 October 2020
Verified
Conference Paper
Closed access
OEOmar ElSherbiny
Omar ElSherbiny
SRSubhanwit Roy
Subhanwit Roy
SCSadaf Charkhabi
Sadaf Charkhabi
ACAdam R. Carr
Adam R. Carr
ABAndee M. Beierle
Andee M. Beierle
NNNathan M. Neihart
Nathan M. Neihart
Ions play a significant role in biological, industrial, and agricultural processes. Noninvasive, real-time detection of their presence and concentration has become of vital importance in a multitude of processes. In this paper, we present a lumped-element circuit model for an Archimedean spiral inductor based resonant sensor which accurately detects and quantifies ionic concentration of aqueous solutions. The development of the model is guided by observed physical phenomena caused by changing a solution's ionic concentration. The system's response to different concentrations of aqueous potassium chloride is measured, and the model parameters are extracted from measured data. The model parameters are extrapolated to obtain expressions that model the system's response over a wide range of concentrations. There is good agreement between the model and measured data, making it valid for concentrations ranging from 1.66 mmol/L to 1 mol/L. The model helps generate insight into the behavior of the physical system, could be used to systematically optimize the sensor design, and could be extended to other analytes.